Literature DB >> 28438869

Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and Helicobacter pylori Infection in Gastric Cancer.

Takashi Fukuyama1, Nobue Futawatari2,3, Yoshinobu Ichiki4, Akiko Shida3, Taiga Yamazaki5, Yatsushi Nishi6, Hiroshi Nonoguchi5, Yoshihito Takahashi3,6, Hitoshi Yamazaki7, Noritada Kobayashi5.   

Abstract

BACKGROUND/AIM: Our previous study indicated that Kita-kyushu lung cancer antigen-1 (KK-LC-1) is a cancer/testis antigen (CTA) expressed in 82% of gastric cancer cases. Here, we investigated the relationship between KK-LC-1 expression and Helicobacter pylori infection in Japanese patients with gastric cancer. PATIENTS AND METHODS: We examined CTA expression in 25 surgical gastric cancer specimens and anti-H. pylori IgGs in the serum of each patient.
RESULTS: KK-LC-1 was expressed in 80% of tumor samples, markedly higher than melanoma antigen gene (MAGE)-A1, MAGE-A3, MAGE-A4, synovial sarcoma, X breakpoint 4 (SSX4) and New York esophageal squamous cell carcinoma-1 (NY-ESO-1). Anti-H. pylori IgG titers from the KK-LC-1-positive patients were significantly higher (67.5±7.6) than those from KK-LC-1-negative patients (15.8±7.5, p<0.01) although there were no significant differences between patients positive and negative for MAGE-A1, -A3 and-A4, SSX4 and NY-ESO-1.
CONCLUSION: As far as we are aware, this is the first report of a correlation between a carcinogen and CTA expression in clinical samples. KK-LC-1 was frequently expressed in gastric cancer caused by H. pylori infection. The risk diagnosis for gastric cancer might be more accurate if KK-LC-1 expression status were also considered. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Helicobacter pylori; KK-LC-1; cancer/testis antigen; carcinogen; gastric cancer

Mesh:

Substances:

Year:  2017        PMID: 28438869      PMCID: PMC5461451          DOI: 10.21873/invivo.11073

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  17 in total

1.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma.

Authors:  Mitsuhiro Takenoyama; Jean-Françis Baurain; Manabu Yasuda; Tomoko So; Masakazu Sugaya; Takeshi Hanagiri; Kenji Sugio; Kosei Yasumoto; Thierry Boon; Pierre G Coulie
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

3.  Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.

Authors:  Shigeto Mizuno; Ikuya Miki; Tsukasa Ishida; Masaru Yoshida; Mitsuko Onoyama; Takeshi Azuma; Yasuki Habu; Hideto Inokuchi; Kotaro Ozasa; Kazumasa Miki; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2010-03-04       Impact factor: 3.199

4.  Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.

Authors:  Akiko Shida; Nobue Futawatari; Takashi Fukuyama; Yoshinobu Ichiki; Yoshihito Takahashi; Yatsushi Nishi; Noritada Kobayashi; Hitoshi Yamazaki; Masahiko Watanabe
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

5.  Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer.

Authors:  Yoshito Nakamura; Fumiaki Tanaka; Hisashi Nagahara; Keisuke Ieta; Naotsugu Haraguchi; Koshi Mimori; Atsushi Sasaki; Hiroshi Inoue; Katsuhiko Yanaga; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2006-12-07       Impact factor: 5.344

6.  Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Marco Tartaglia; Charlotte M Niemeyer; Alessandra Fragale; Xiaoling Song; Jochen Buechner; Andreas Jung; Karel Hählen; Henrik Hasle; Jonathan D Licht; Bruce D Gelb
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

7.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

8.  Correlation between the ABC classification and radiological findings for assessing gastric cancer risk.

Authors:  Takahiro Itoh; Miho Saito; Nagaaki Marugami; Toshiko Hirai; Aki Marugami; Junko Takahama; Toshihiro Tanaka; Kimihiko Kichikawa
Journal:  Jpn J Radiol       Date:  2015-08-07       Impact factor: 2.374

Review 9.  The cancer/testis genes: review, standardization, and commentary.

Authors:  Matthew J Scanlan; Andrew J G Simpson; Lloyd J Old
Journal:  Cancer Immun       Date:  2004-01-23

10.  Non-invasive diagnosis of H pylori infection: evaluation of serological tests with and without current infection marker CIM.

Authors:  Sufi-H Z Rahman; M-Golam Azam; M-Anisur Rahman; M-S Arfin; M-Mahbub Alam; Tareq-M Bhuiyan; Nasim Ahmed; Motiur Rahman; Shamsun Nahar; M-S Hassan
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

View more
  6 in total

1.  MAEL Cancer-Testis Antigen as a Diagnostic Marker in Primary Stages of Gastric Cancer with Helicobacter pylori Infection.

Authors:  Mohammad Reza Abbaszadegan; Negin Taghehchian; Azadeh Aarabi; Meysam Moghbeli
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.

Authors:  Nobue Futawatari; Takashi Fukuyama; Rui Yamamura; Akiko Shida; Yoshihito Takahashi; Yatsushi Nishi; Yoshinobu Ichiki; Noritada Kobayashi; Hitoshi Yamazaki; Masahiko Watanabe
Journal:  World J Gastroenterol       Date:  2017-12-14       Impact factor: 5.742

3.  Targeted photodynamic therapy of cancer using a novel gallium (III) tris (ethoxycarbonyl) corrole conjugated-mAb directed against cancer/testis antigens 83.

Authors:  Ziyu Ye; Yanfang Liang; Yan Ma; Bihua Lin; Longbin Cao; Bin Wang; Zhao Zhang; Haibo Yu; Jixia Li; Mingyuan Huang; Keyuan Zhou; Qunzhou Zhang; Xinguang Liu; Jincheng Zeng
Journal:  Cancer Med       Date:  2018-06-01       Impact factor: 4.452

4.  Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling.

Authors:  Zhiqiang Chen; Xueliang Zuo; Liyong Pu; Yao Zhang; Guoyong Han; Long Zhang; Zhengshan Wu; Wei You; Jianjie Qin; Xinzheng Dai; Hongbing Shen; Xuehao Wang; Jindao Wu
Journal:  Cell Prolif       Date:  2019-03-20       Impact factor: 6.831

Review 5.  Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen.

Authors:  Rui Bai; Cheng Yuan
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

6.  Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers.

Authors:  Akiko Shida; Takashi Fukuyama; Nobue Futawatari; Haruki Ohmiya; Yoshinobu Ichiki; Tetsuro Yamashita; Yatsushi Nishi; Noritada Kobayashi; Hitoshi Yamazaki; Masahiko Watanabe; Yoshihito Takahashi
Journal:  World J Gastroenterol       Date:  2020-01-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.